![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/868611/a-first-in-class-broad-spectrum-antiviral-agent-intending-to-revolutionize-treatment-of-viral-infections-including-rsv-covid-influenzas-and-more
https://www.accesswire.com/866670/nanoviricides-bolsters-partnership-efforts-engages-aagami-inc
https://www.accesswire.com/865315/lethally-rsv-infected-animals-orally-treated-with-nv-387-showed-normal-lung-histology-indicating-potential-cure
https://www.accesswire.com/863489/nanoviricides-has-filed-its-quarterly-report
https://www.accesswire.com/861804/nanoviricides-to-participate-in-the-2024-ef-hutton-annual-global-conference-on-may-15-in-new-york-city